Status: current, Primitive. Date: 30-Apr 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5035109012 | Larotrectinib sulfate | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 5035110019 | Larotrectinib sulfate (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Larotrectinib sulfate | Is a | Pyrazole derivative | true | Inferred relationship | Some | ||
| Larotrectinib sulfate | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Larotrectinib sulfate | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Larotrectinib sulfate | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Larotrectinib sulfate | Is a | Pyrimidine | true | Inferred relationship | Some | ||
| Larotrectinib sulfate | Has disposition | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Larotrectinib sulfate | Is modification of | Larotrectinib | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Larotrectinib (as larotrectinib sulfate) 20 mg/mL oral solution | Has precise active ingredient | True | Larotrectinib sulfate | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR